|
|||||
|
|
A Phase II Trial of Selinexor,an Oral Selective Inhibitor of Nuclear Export Compound,in Abiraterone‐ and/or Enzalutamide‐Refractory Metastatic Castration‐Resistant Prostate Cancer |
|
| Authors: | Xiao X. Wei Adam P. Siegel Rahul Aggarwal Amy M. Lin Terence W. Friedlander Lawrence Fong Won Kim Mirela Louttit Emily Chang Li Zhang Charles J. Ryan |
| Affiliation: | Division of Hematology/Oncology, University of California, San Francisco, San Francisco, California, USA |
| Abstract: | |
| Keywords: | |